MANUFACTURERS LIFE INSURANCE COMPANY, THE - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 128 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$191,622
-32.7%
27,974
+1.8%
0.00%
Q2 2023$284,833
+41.3%
27,467
+10.2%
0.00%
Q1 2023$201,651
-48.6%
24,9260.0%0.00%
Q4 2022$392,585
+6.6%
24,926
+6.6%
0.00%
Q3 2022$368,111
+10.6%
23,387
-1.9%
0.00%
Q2 2022$332,737
-8.9%
23,835
+12.5%
0.00%
Q1 2022$365,402
-5.1%
21,195
-20.0%
0.00%
Q4 2021$385,000
-19.5%
26,495
-0.3%
0.00%
Q3 2021$478,000
+10.1%
26,579
+7.5%
0.00%
Q2 2021$434,000
+183.7%
24,715
-3.5%
0.00%
Q1 2019$153,000
+54.5%
25,617
+92.2%
0.00%
Q4 2018$99,000
-35.7%
13,329
+25.3%
0.00%
Q3 2018$154,000
-63.3%
10,634
-49.4%
0.00%
Q2 2018$420,000
+32.5%
21,001
+15.8%
0.00%
Q1 2018$317,000
-29.9%
18,135
-1.1%
0.00%
Q4 2017$452,000
-0.7%
18,333
+4.1%
0.00%
-100.0%
Q3 2017$455,000
+6.1%
17,608
+11.2%
0.00%0.0%
Q2 2017$429,000
+54.3%
15,831
+69.7%
0.00%
Q1 2017$278,000
+31.8%
9,329
+20.2%
0.00%
Q4 2016$211,000
+9.9%
7,762
+3.2%
0.00%
Q3 2016$192,000
+38.1%
7,5200.0%0.00%
Q2 2016$139,000
+117.2%
7,520
+83.0%
0.00%
Q1 2016$64,0004,1100.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,954,904$49,264,00043.26%
COMMODORE CAPITAL LP 1,028,084$25,908,00010.32%
Foresite Capital Management IV, LLC 3,399,034$85,656,00010.26%
VR Adviser, LLC 3,720,582$93,759,00010.17%
Parkman Healthcare Partners LLC 1,709,136$43,070,00010.00%
Foresite Capital Management V, LLC 1,258,243$31,708,0009.32%
Stenahm Asset Managment Ltd 283,500$7,144,0005.04%
Samsara BioCapital, LLC 1,022,612$25,770,0004.75%
SILVERARC CAPITAL MANAGEMENT, LLC 336,737$8,486,0004.63%
Ghost Tree Capital, LLC 600,000$15,120,0003.55%
View complete list of ACLARIS THERAPEUTICS INC shareholders